EvoNext Holdings SA (ELVAF)
OTCMKTS · Delayed Price · Currency is USD
1.100
-0.050 (-4.35%)
At close: Oct 10, 2025
EvoNext Holdings Market Cap
EvoNext Holdings has a market cap or net worth of $7.87 million as of February 12, 2026. Its market cap has decreased by -8.55% in one year.
Market Cap
7.87M
Enterprise Value
-312.26K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.10
Market Cap Chart
Since March 1, 2010, EvoNext Holdings's market cap has decreased from 361.87M to 7.87M, a decrease of -97.82%. That is a compound annual growth rate of -21.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 7.87M | 6.54% |
| Dec 30, 2025 | 7.39M | 3.25% |
| Dec 30, 2024 | 7.16M | 22.89% |
| Dec 29, 2023 | 5.82M | -94.09% |
| Dec 30, 2022 | 98.47M | -29.13% |
| Dec 30, 2021 | 138.93M | -21.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TRON Group | 11.43M |
| AccuStem Sciences | 10.19M |
| Inhibitor Therapeutics | 9.79M |
| Biomind Labs | 8.84M |
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 7.75M |
| BetterLife Pharma | 7.44M |
| Synlogic | 7.17M |